International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) - Wikidata - awgldk - TriplyDB

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

http://www.wikidata.org/entity/Q28292418

about

Antiplatelet and anticoagulant agents for preventing recurrence of peripheral vascular thrombosis in patients with Antiphospholipid syndrome Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Assessment of the 2006 revised antiphospholipid syndrome classification criteria Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay Systemic lupus erythematosus: strategies to improve pregnancy outcomes Impact of Antiphospholipid Syndrome and/or Systemic Lupus Erythematosus on the Long-term Adverse Cardiovascular Outcomes in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease What nephrolopathologists need to know about antiphospholipid syndrome-associated nephropathy: Is it time for formulating a classification for renal morphologic lesions?Lupus enteritis: from clinical findings to therapeutic management Antiphospholipid Antibodies and Antiphospholipid Syndrome during Pregnancy: Diagnostic Concepts The role of the gut microbiota in the pathogenesis of antiphospholipid syndrome Obstetrical antiphospholipid syndrome: from the pathogenesis to the clinical and therapeutic implications Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment Managing lupus patients during pregnancy AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION): 5-Year Update The role of thrombophilia in pregnancy A Novel Dimeric Inhibitor Targeting Beta2GPI in Beta2GPI/Antibody Complexes Implicated in Antiphospholipid Syndrome The roles of anatomic factors, thrombophilia, and antithrombotic therapies in childhood-onset arterial ischemic stroke Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis.Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome Dysfunction in the coagulation system and schizophrenia Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events?The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging Examining the prevalence of non-criteria anti-phospholipid antibodies in patients with anti-phospholipid syndrome: a systematic review Associations of antiphospholipid antibodies with splanchnic vein thrombosis: a systematic review with meta-analysis Anti-inflammatory and immunosuppressive drugs and reproduction Lupus anticoagulant and ischemic myocardial microangiopathy in rheumatoid arthritis Placental histology and neutrophil extracellular traps in lupus and pre-eclampsia pregnancies Effect of Low Molecular Weight Heparins (LMWHs) on antiphospholipid Antibodies (aPL)-mediated inhibition of endometrial angiogenesis Diagnosis and management of catastrophic antiphospholipid syndrome.Systematic review of case reports of antiphospholipid syndrome following infection.Direct oral anticoagulants in hypercoagulable states.Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2.

P2860

Q24185813-A3ED783F-AF45-49BA-9067-4E17AFFCEE5E Q24185949-81BCD98A-77F8-43E3-A8D6-0BCBA55BF30F Q24194917-AE688B40-FE95-4F64-A925-CE81537F1319 Q24632951-1775B191-FFB9-494F-AB49-6CFA84CF8EB6 Q24632982-826F72CC-09FD-4D3E-8B2F-8371273011B9 Q24648632-5D2137C6-AD6A-4E59-892D-2EEAFBCEB4DA Q26739950-FEE5E45F-8E42-4B9C-8203-451D090FD6FF Q26741149-58ABAEA3-B82E-4AC4-BEA7-527E81BEB370 Q26750752-21A624CA-63D2-4B5E-89EF-C9C1C172DEA6 Q26766428-94C7C879-5CFB-47B0-A0BF-8FDBEA47F9B8 Q26825077-91BBAB39-3E88-4894-A770-382305AA66E0 Q26825218-F330D9C8-CD28-47A4-A962-C766D01F4F3E Q26829733-EFB77987-0713-4CEE-AE8C-E066A86E4C38 Q26852537-4F7F2EB3-F9AE-47F9-AE7E-773C667FD436 Q26866133-DF332FC8-C306-41E8-85DE-B05F6FB8AB0F Q26998188-F7D67110-8AF4-4CC6-BF4C-6289C27A9E8C Q26999284-17A43154-2A3D-4DA5-A195-094A3C1B9BE5 Q26999710-D63AEF4F-F8A7-4F14-81F0-CE5C21EBEB2A Q27002228-9312010A-BB4F-4852-855B-1E7A4E0977CC Q27007774-3FB337A8-4B28-4AC8-A295-A9E98EFEB8C9 Q27021687-75389E4A-4F34-4CD3-A909-4DE2EBC10107 Q27666379-7808A9D5-E9B2-4D71-B6BA-BCDED0DB75E7 Q27687644-66644DB4-86D6-4BA5-8C0D-C8619D413779 Q27692668-192C9AFE-747D-413B-BAE4-97D2222088E9 Q28067420-7C9855C8-E5E0-4739-A352-E1E27001FCC4 Q28068412-AB335C1D-B87A-4948-8CFD-E5FFE5B82BDE Q28071739-7DD37E2A-E4CD-4701-B4CD-8ADD9D3FECD1 Q28072610-183AF43D-F86D-4BFB-8CCF-9E524CC0B054 Q28081442-01747AA2-9C06-48CB-81EF-593332DF77FC Q28081765-3AC8DEB4-7E48-4584-99B9-6AFCB3C367B1 Q28082873-B8DA8970-00D5-49CB-BBFD-6D2D779CCE95 Q28218219-38B73710-1656-4B23-A12E-53441495D9D6 Q28218493-315D16B8-7178-41A9-A7FA-6A6DC601EC3C Q28603356-62C12464-039A-45B2-B138-07346BC232A8 Q28740531-47FBD32A-D722-4352-9DC7-4611C6C21055 Q30235356-02F8A252-7E5D-4364-B9C9-3B7C75CB15F2 Q30243901-336A6123-19AB-443E-AE16-6DBDFEE5C6A9 Q30275936-F991AF6A-01E6-40C4-89AF-28DA14923324 Q30355477-002B8020-1C6D-4B22-AD69-E82F16BAD081 Q30497721-B2C955D5-7F13-40DE-8365-AE53A87FD954

P2860

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

http://www.wikidata.org/entity/Q28292418

description

2006 nî lūn-bûn

@nan

2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

name

International consensus statem ...... ntiphospholipid syndrome (APS)

@ast

International consensus statem ...... ntiphospholipid syndrome (APS)

@en

International consensus statem ...... ntiphospholipid syndrome (APS)

@nl

type

label

International consensus statem ...... ntiphospholipid syndrome (APS)

@ast

International consensus statem ...... ntiphospholipid syndrome (APS)

@en

International consensus statem ...... ntiphospholipid syndrome (APS)

@nl

prefLabel

International consensus statem ...... ntiphospholipid syndrome (APS)

@ast

International consensus statem ...... ntiphospholipid syndrome (APS)

@en

International consensus statem ...... ntiphospholipid syndrome (APS)

@nl

P1433

Q28292418-D6AE9772-9E03-4025-99F3-149C4E66356E

P1476

Q28292418-A725DB53-05DF-4942-BC50-F93B2AAE8563

P2093

Q28292418-34C56F58-0090-48A7-94F6-2512D1143D11

Q28292418-4344C66E-A2E5-40CC-BDF5-9F05D81B7A00

Q28292418-696B049F-A847-4D38-A562-24B2B77F0430

Q28292418-7DD0C8E5-5240-4DF9-A837-FC74CEA739D0

Q28292418-CE3A569D-5D03-4718-9273-296A7A05652C

Q28292418-D1B6CF28-2AE5-48DD-8756-D82080FD0FC2

Q28292418-E0620E80-168A-42F7-BBAC-963F455B72F7

Q28292418-EB8B50FC-6713-485C-98D6-66EF89931F87

P2860

Q28292418-1F00767C-C62B-43AD-ADE3-ED6F3608C580

Q28292418-380F7938-BF81-4B6E-925D-7A56B1682CD4

Q28292418-77163E1C-B612-437B-905C-82DEF1790816

Q28292418-FF657231-4801-4A3D-AED9-AAC078EF5618

P304

Q28292418-FEFFC9FB-62FC-4D04-AC3F-1596FD1E856A

P31

Q28292418-D25B0BF6-E105-490F-A4BC-AB00B8BFFF27

P3181

Q28292418-34A9A194-7F15-4C9D-98FF-8ECBAECF3381

P356

Q28292418-C54B380E-B5E8-45C3-AF01-87FF4196404B

P407

Q28292418-335A9DED-0608-4D1F-9430-E2C156CB425E

P433

Q28292418-C9426673-E246-4E7B-87EC-B11701376CD5

P478

Q28292418-07390199-5E51-41EF-A2EC-0BDF849445B0

P50

Q28292418-3D5C23E2-44C4-48E2-8E4A-E6A9417F717E

Q28292418-587DED8B-A871-4121-A0B1-968580A53930

Q28292418-5969E3F9-C1C3-4F4B-9D4C-B2930989F119

Q28292418-5F749B60-E71C-4FE9-8DFF-178A824F6AFA

Q28292418-842380EE-3764-48A4-8DED-75CAD4B86F04

Q28292418-8DA963C2-FCE9-458F-8103-0B335B70312C

Q28292418-A154ECD8-44BE-4A84-AD94-C1D5CBBC40F6

P577

Q28292418-E078B887-D976-4A2B-B4FA-1E6FBC272E8F

P5875

Q28292418-468D5876-BCBF-4855-B05E-040947C1F34B

P698

Q28292418-EB5741BC-5E09-4EED-A8C1-BCA2F9FF0B4B

P3181

P356

J.1538-7836.2006.01753.X

P1433

Journal of Thrombosis and Haemostasis

P1476

International consensus statem ...... ntiphospholipid syndrome (APS)

@en

P2093

D W Branch

http://www.w3.org/2001/XMLSchema#string

G Reber

http://www.w3.org/2001/XMLSchema#string

P G DE Groot

http://www.w3.org/2001/XMLSchema#string

P G Vlachoyiannopoulos

http://www.w3.org/2001/XMLSchema#string

R L Brey

http://www.w3.org/2001/XMLSchema#string

S A Krilis

http://www.w3.org/2001/XMLSchema#string

S Miyakis

http://www.w3.org/2001/XMLSchema#string

T Atsumi

http://www.w3.org/2001/XMLSchema#string

P2860

Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Antiphospholipid antibodies in women at risk for preeclampsia

Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome

P304

295-306

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

348796

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/J.1538-7836.2006.01753.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Michael D. Lockshin

Yehuda Shoenfeld

Pier Luigi Meroni

Ronald H. W. M. Derksen

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7351178

http://www.w3.org/2001/XMLSchema#string

P698

16420554

http://www.w3.org/2001/XMLSchema#string